Shu Y - Search Results

1

Clinical significance of PIK3CA and survivin in primary adenosquamous lung carcinoma.

Yu S, Zhang Z, Zhang B, Shu Y, Wu H, Huang X, Yu Q, Guo R. Yu S, et al. Among authors: shu y. Med Oncol. 2014 Jun;31(6):983. doi: 10.1007/s12032-014-0983-7. Epub 2014 May 17. Med Oncol. 2014. PMID: 24838432

2

Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells.

Wu H, Li W, Wang T, Shu Y, Liu P. Wu H, et al. Among authors: shu y. Biomed Pharmacother. 2008 Nov;62(9):659-66. doi: 10.1016/j.biopha.2008.08.002. Epub 2008 Aug 31. Biomed Pharmacother. 2008. PMID: 18809274

3

Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.

Guo R, Huang Z, Shu Y, Jin S, Ge H. Guo R, et al. Among authors: shu y. Biomed Pharmacother. 2009 Jun;63(5):375-9. doi: 10.1016/j.biopha.2008.09.010. Epub 2008 Oct 23. Biomed Pharmacother. 2009. PMID: 18993026

4

[Insulin/PI3K signalling pathway regulates the expression of survivin in liver cancer HepG2 cells].

Guo RH, Jin SD, Cai J, Huang ZH, Shu YQ. Guo RH, et al. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):745-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173802 Chinese.

5

Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2.

Guo R, Wang T, Shen H, Ge HM, Sun J, Huang ZH, Shu YQ. Guo R, et al. Biomed Pharmacother. 2010 Apr;64(4):249-53. doi: 10.1016/j.biopha.2009.06.007. Epub 2009 Oct 22. Biomed Pharmacother. 2010. PMID: 19931998

6

The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer.

Wang RS, Liu LX, Gu YH, Lin QF, Guo RH, Shu YQ. Wang RS, et al. Biomed Pharmacother. 2010 May;64(5):309-12. doi: 10.1016/j.biopha.2009.09.011. Epub 2009 Nov 5. Biomed Pharmacother. 2010. PMID: 19942398

7

Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance.

Shen L, Zhu Z, Huang Y, Shu Y, Sun M, Xu H, Zhang G, Guo R, Wei W, Wu W. Shen L, et al. Among authors: shu y. Biomed Pharmacother. 2010 May;64(5):313-8. doi: 10.1016/j.biopha.2009.12.003. Epub 2010 Jan 8. Biomed Pharmacother. 2010. PMID: 20106632

8

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis.

Gao W, Shen H, Liu L, Xu J, Xu J, Shu Y. Gao W, et al. Among authors: shu y. J Cancer Res Clin Oncol. 2011 Apr;137(4):557-66. doi: 10.1007/s00432-010-0918-4. Epub 2010 May 28. J Cancer Res Clin Oncol. 2011. PMID: 20508945

9

[Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer.].

Wang T, Sun J, Gao W, Shen H, Li X, Yin Y, Shu Y, Guo R. Wang T, et al. Among authors: shu y. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1287-90. doi: 10.3779/j.issn.1009-3419.2009.12.12. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723385 Free article. Chinese.

10

[Down-regulation of mTOR activity and survivin expression during tamoxifen-induced apoptosis in hepatoblastoma cells].

Guo RH, Wang TS, Chen XF, Huang ZH, Shu YQ. Guo RH, et al. Zhonghua Zhong Liu Za Zhi. 2010 Dec;32(12):903-6. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21223797 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,861 results

Search Page

Filters